NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance. - Wikidata - awgldk - TriplyDB

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

http://www.wikidata.org/entity/Q30486628

about

Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy Strategies for combining immunotherapy with radiation for anticancer therapy Cancer stem cells and radioresistance Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells.Nanoparticles for live cell microscopy: A surface-enhanced Raman scattering perspective.Breast cancer stem cells: Multiple capacities in tumor metastasis.The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells.Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics The role of radiotherapy-resistant stem cells in breast cancer recurrence.Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.HER2 and breast cancer stem cells: more than meets the eye.Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia.Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation.HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44(+)/CD24(-/low) Stem Cell Phenotype.Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo.Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets.β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART).Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance.Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells.Gamma-irradiation induces HER-2/neu overexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab.EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.Rac1 is a potential target to circumvent radioresistance Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer.A novel HER2 gene body enhancer contributes to HER2 expression.Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers.

P2860

Q26777016-82A112BC-E8A2-440B-9985-CD03884AE271 Q26796675-08AEDC0F-304F-42BB-BC1A-B3F3624B217F Q27008368-9BC7CB7B-6DA1-42AF-BA05-E3EB867FD77C Q33589345-89215349-908B-4962-8BDE-95067024EBEE Q33860870-025EB261-5EA6-44DB-A266-782B33252202 Q34257303-1B4C3469-BB1D-4446-83FB-6E63E0005314 Q34482547-2B536B8C-51A0-446C-A558-05B4E1DADEC4 Q34713726-83D9665A-E2DC-48B1-BDEE-5ED716AED615 Q34855520-457BA908-C4BB-40DB-BA19-5D10F0A64C71 Q34972167-00F8A36C-998C-4B16-B2B1-F61E2A3FD029 Q35051875-DD388FEF-B77C-44C5-97D8-533829B30C1E Q35320325-15113AE7-707E-4FCE-881F-3AFB667571AC Q35667318-621C4B67-3820-4AE7-B5D9-A98F1D830EB0 Q35806672-E6774151-3025-429F-88AA-543A854D56CF Q36160375-FFD41DAB-E81C-4043-816E-FE1414A2F12D Q36280791-15E2CAA8-A9E4-41A7-A85B-F28643DD366A Q36666667-AC2E3726-F867-4B0A-BDC3-D8B4A19CD545 Q36670686-2E790631-95DA-46DC-9693-68E0D00997FC Q36693285-04D67523-FF37-47EC-AD32-57038FBDFEB9 Q36999723-9D70739F-8C46-4237-8112-B1D71F7E9083 Q37376369-C1FC5FE3-12B7-4A17-B67C-D45E1B9F5CC8 Q37470093-2BEB5463-9B39-427F-99A3-3428D14F634D Q37564374-15F2D25C-8EF0-4C32-9A08-AD09D7483824 Q37650735-EA705288-4045-47D7-B8C1-AA0DF2793180 Q37689916-845FC48F-6FAD-4BC4-BD58-9E62C0EE955F Q38255668-C2A2B903-5576-4682-AF96-C65751EFA94D Q38365298-60C1B7F6-FB3A-4E29-8EC1-F7EA5DD60095 Q38371280-4FC89D03-4A68-4321-845E-A170E525CF0A Q38681083-7ED844D5-F93D-41EA-B1B0-AF6B307862A1 Q38726934-821A54D8-35B3-4D15-AD80-E3A129415EC3 Q38735527-8520179C-ECAE-4ECD-9ECC-67D5CF56655A Q38856771-0C437206-FC72-49D8-9EF3-D31EB926CC36 Q38999358-07C250B6-2604-450E-9F5F-49B10AE06627 Q39212216-4A5DDB7E-BED8-4299-BE1D-274FF47DFA3E Q39372010-5CC92C4F-281E-4016-8F7B-CCA98A8A2161 Q39718274-10D9BBC1-5B1A-43F4-A050-BE40BCAB11EC Q41592633-035D3200-5ACC-491F-8381-639E16007B99 Q47596281-CBF46EF2-8CBE-40BC-B8B0-CA807C336C75 Q49528668-E7B5EBE0-1695-470D-8635-C1271345564D Q53685106-369B16DA-168B-4CA0-AC50-36B493D9B487

P2860

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

http://www.wikidata.org/entity/Q30486628

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@ast

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@en

type

label

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@ast

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@en

prefLabel

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@ast

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@en

P1433

Q30486628-567E8A14-B6D7-46F4-A1F2-557FD071A61B

P1476

Q30486628-F5206CAA-B78C-4FE6-8900-0DD82096CD05

P2093

Q30486628-2958F3BB-F5B2-40C4-B22D-1D20BBA0F7E7

Q30486628-2CCD0D73-1BAB-495A-AC78-A8C1DA3915B7

Q30486628-4ED9AC42-8358-4BAA-9469-C9384236927A

Q30486628-60658900-E3DB-4E8F-B859-6CE4840B01EC

Q30486628-7F3B72C6-8417-466F-8531-9AE706C219A3

Q30486628-A915715D-BBB2-402D-AFDA-0FD47876E376

Q30486628-B6D98274-A0A6-44AB-BEE7-EC2B51E98F74

Q30486628-EFD660BD-26A3-4FCF-9EC3-07EEE6190CF5

P2860

Q30486628-0050EC03-FE0A-40C1-85EF-5A032EAAE335

Q30486628-044D9681-8086-4781-A4A8-55AF824284C7

Q30486628-133A9778-E402-46DA-A1C1-76FAE9412772

Q30486628-14690F2C-66A7-4257-BD06-D14B56706637

Q30486628-18D3D253-C9F2-44FC-8CEF-80A7059FF764

Q30486628-1ED0C54C-095E-443C-A015-B14FBF9003D9

Q30486628-1F1D7F80-B1A1-49EA-A05D-9C6023163B25

Q30486628-1FAB188C-2C63-439A-B227-C5DDFA61771E

Q30486628-23C6FAEE-3DAA-4BD9-85A6-27F195143514

Q30486628-28D98C71-1DED-4455-91CD-F257F70321EF

P304

Q30486628-FFF3DD22-E167-47E0-8CE1-02242AF38F73

P31

Q30486628-4D9D3E21-10E7-4EF2-BBD5-C9F0E6E6A4D3

P356

Q30486628-26A684F1-BA69-4B3D-8724-3A32939B2975

P433

Q30486628-F4119EA6-C150-4691-AA17-45486E376259

P478

Q30486628-8D4A89A5-A9F8-48D7-AC2B-BCB880D7C5AE

P577

Q30486628-85D4F0C2-E19F-4715-A4C7-D71EADB59998

P5875

Q30486628-96E8D258-34B5-41A0-964D-766BB99B1A42

P698

Q30486628-2F98C505-897E-421C-9A47-8C5D36B4A779

P921

Q30486628-2C74BB2F-0780-4806-9031-796B9DBD4E75

Q30486628-325BD74C-10CC-4967-BB64-AAB02A6CC486

P932

Q30486628-AE64B2BA-3C79-4C0A-BD62-E6DCF1BC8954

P356

P1433

Radiation Research

P1476

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

@en

P2093

Jian Jian Li

http://www.w3.org/2001/XMLSchema#string

Joseph R Dynlacht

http://www.w3.org/2001/XMLSchema#string

Kazi Mokim Ahmed

http://www.w3.org/2001/XMLSchema#string

Michael E Degnan

http://www.w3.org/2001/XMLSchema#string

Ming Fan

http://www.w3.org/2001/XMLSchema#string

Ning Cao

http://www.w3.org/2001/XMLSchema#string

Shiyong Li

http://www.w3.org/2001/XMLSchema#string

Zhaoqing Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

Prospective identification of tumorigenic breast cancer cells

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Stem cells, cancer, and cancer stem cells

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation.

P304

9-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1667/RR1472.1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23781310

http://www.w3.org/2001/XMLSchema#string

P698

19138055

http://www.w3.org/2001/XMLSchema#string

P921

P932

2659759

http://www.w3.org/2001/XMLSchema#string